ThredUp to Participate in Morgan Stanley Conference
OAKLAND, Calif., March 05, 2024 (GLOBE NEWSWIRE) — ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms […]
Cricut, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Delivered 7th consecutive year of profitability with net income of $53.6 million, or 7.0% margin Generated $288.1 million in Cash […]
Postal Realty Trust to Present at Sidoti Virtual Investor Conference March 13
CEDARHURST, N.Y., March 05, 2024 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real […]
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
— Preliminary data from Phase 2 portion of Phase 2/3 study evaluating GRANITE, Gritstone’s personalized cancer vaccine in front-line metastatic, […]
Full House Resorts Announces Fourth Quarter and Full-Year Results
– Revenues Increased 66.4% to $60.0 Million in the Fourth Quarter of 2023;Annual Revenues Grew 47.6% – Chamonix Casino Hotel […]
Weyco Reports Fourth Quarter and Full Year 2023 Results
MILWAUKEE, March 05, 2024 (GLOBE NEWSWIRE) — Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced […]
HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Fourth quarter revenue totaled $155.8 million, representing an increase of 15% year-over-year; fiscal 2024 revenue totaled $583.1 million, representing an […]
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsExpect to report DREAM U.S. pivotal study efficacy and […]
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced […]
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical […]
